Document Detail

External beam radiation therapy for choroidal neovascularization.
MedLine Citation:
PMID:  9442775     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: This study aimed to determine the effect of external beam radiation therapy on choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). DESIGN: The study design was a nonrandomized clinical trial with an historic control group. PARTICIPANTS: A total of 91 patients were treated with external beam radiation. These patients were compared retrospectively to the 119 patients in a control group. INTERVENTION: Patients with subfoveal CNV who did not meet the criteria for laser treatment defined by published reports from the Macular Photocoagulation Study Group or who did not want laser treatment were considered for radiation therapy in a nonrandomized, prospective clinical trial. Additional entry criteria for this prospective study included visual acuity better than or equal to 20/320 on the Early Treatment Diabetic Retinopathy Study chart and a lesion size less than 12 disc areas. The patients were treated with 5 fractions of 200 cGy 6 MV external beam photons. MAIN OUTCOME MEASURES: The visual acuity measured at baseline was compared to the visual acuity after 1 year of follow-up. RESULTS: The mean baseline visual acuity of the 91 patients entered into the Radiation Study was 20/80. After 1 year, 83 patients (91.2%) completed follow-up, and their mean visual acuity dropped to 20/200. By comparison, the mean baseline visual acuity of the control patients also was 20/80, and after 1 year, the control subjects had a mean visual acuity of 20/125. At 1 year of follow-up, 49.4% of patients treated with radiation and 38.1% of the control subjects lost 3 or more lines of visual acuity (P = 0.16). CONCLUSIONS: This study found that external beam radiation using 1000 cGy in 5 fractions, a dose similar to that used in previous studies, was not effective in the treatment of CNV secondary to AMD. These results suggest that patients should not be treated with this dose of external beam radiation for CNV secondary to AMD.
R F Spaide; D R Guyer; B McCormick; L A Yannuzzi; K Burke; M Mendelsohn; A Haas; J S Slakter; J A Sorenson; Y L Fisher; D Abramson
Related Documents :
9373105 - Epidemic bacillus endophthalmitis after cataract surgery i: acute presentation and outc...
20415625 - Intravitreal bevacizumab combined with intravitreal triamcinolone for therapy-resistant...
14566625 - Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical co...
23140035 - Validation of euroscore for coronary artery bypass grafting at siriraj hospital.
24958185 - Epistaxis and dabigatran, a new non-vitamin k antagonist oral anticoagulant.
23973155 - The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial flui...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Ophthalmology     Volume:  105     ISSN:  0161-6420     ISO Abbreviation:  Ophthalmology     Publication Date:  1998 Jan 
Date Detail:
Created Date:  1998-01-30     Completed Date:  1998-01-30     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  7802443     Medline TA:  Ophthalmology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  24-30     Citation Subset:  IM    
Vitreous, Retina, Macula Consultants of New York, LuEsther T. Mertz Retina Research Laboratory, New York 10021, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Choroid / blood supply*
Coloring Agents / diagnostic use
Dose Fractionation
Fluorescein Angiography
Follow-Up Studies
Fundus Oculi
Indocyanine Green / diagnostic use
Macular Degeneration / complications*
Neovascularization, Pathologic / etiology,  physiopathology,  radiotherapy*
Prospective Studies
Radiotherapy, High-Energy*
Visual Acuity / physiology
Reg. No./Substance:
0/Coloring Agents; 3599-32-4/Indocyanine Green
Comment In:
Ophthalmology. 1998 Oct;105(10):1789-90   [PMID:  9787338 ]
Ophthalmology. 1998 Oct;105(10):1792-3; author reply 1793-4   [PMID:  9787340 ]
Ophthalmology. 1998 Oct;105(10):1790-1; author reply 1791-2   [PMID:  9787339 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical tr...
Next Document:  Retinal oxygen consumption during hyperglycemia in patients with diabetes without retinopathy.